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The increasing incidence of gonococcal infection in the United
States is due in large part to the reservoir formed by the large
number of female and male asymptomatic carriers. Control of the
disease would be facilitated by a rapid diagnostic test suitable
for screening the general population for asymptomatic carriers.
A radioimmunoassay which employs an antigen specific for
Neisseria gonorrhoeae contained in an ethanol precipitate of a
surfactant extract of T1 phase gonococci recently has been de
veloped for the detection of antibodies specific for the gonococcus in human serum. In the present project, the chemical,
physical, and biological properties of the gonococcal specific
antigen were studied. In a major portion of this work an inhi
bition assay was employed. Treatments designed to destroy or al
ter specifically various components were performed on unlabeled
antigen. This treated antigen was then tested for capacitiy to
inhibit the specific binding of labeled antigen by human antigonococcal serum. It was found that gonococcal specific anti
genic activity was destroyed by boiling for 5 min, by digestion
with proteolytic enzymes, and by periodate oxidation. Antigenic
activity was not destroyed by heating at 56 C for 1 hr, by treat
ment with 0.1 N acid or alkali, by saponification, or by diges
tion with ribonuclease or deoxyribonuclease. It was found that
the specific antigen was not contained in T3 phase gonococci or
in an endotoxin preparation of T1 phase gonococci. A fraction
containing specific antigenic activity was eluted in the void
volume from Sephadex G-200. Fractions containing specific anti
genic activity were found in the regions of 40% and 10% sucrose
following untracentrifugation on a sucrose gradient.
A model for the structure of the gonococcal specific antigen
was proposed which could account for these findings.
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CHAPTER I

INTRODUCTION

Gonorrhea is the number one reportable infectious disease in the
United States today (9, 49).

While treatment of the disease is rela

tively simple, diagnosis can be difficult (63).

In females, even with

acute infection, symptoms may be absent or go unnoticed, so that many
women go untreated and become chronic, asymptomatic carriers (35).

In

males, although symptoms are more often noticed and treatment sought,
the rate of asynçtomatic carriers is surprisingly high (21).

It has

been reported that as many as 68% of infected males may be asymptomatic
(21).

Present diagnostic procedures which include culturing (32, 62),

gram staining smears and fluorescent antibody techniques (14, 18, 32, 64,
66, cf. 55), are expensive and time consuming.

This renders them im

practical for screening large numbers of people (63).

These procedures

are usually not performed unless gonorrhea is suspected, either from
overt symptoms or a history of sexual contact with an individual known
to be infected.

Because the great number of asymptomatic carriers form

a reservoir from which the disease is disseminated, eradication will not
be achieved until a method is available which is suitable for screening
the general population for carriers (57).

A blood test, because of the

ease of sample collection and social acceptability, would be ideal.
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Numerous investigators have studied the gonococcus with the aim of
finding an antigenic component which would provide a reagent suitable
for detecting humoral antibodies specific for the gonococcus.

This

would be the first step toward development of a sérodiagnostic test for
gonorrhea.

Among the antigens studied have been whole cells (14, 37),

protoplasm (2, 3, 11, 13, 29, 30, 51, 54, 58), pili (8, 52), endotoxin
(17, 38-46, 61), and ribosomes (26).

Whole cells (64, 66) and proto

plasmic extracts (2, 3, 11, 13, 30, 51, 54, 58) have been used in com
plement fixation and gel diffusion tests.

Antibodies in the serum of

patients have been found which reacted with these preparations, but no
assay has been clinically acceptable.

Major problems encountered with

seroassays have been high rates of false positive reactions (3, 14, 30,
33, 37, 53), high rates of false negative reactions (3, 23, 33, 37),
and lack of sensitivity

(23, 54, cf. 55).

Also, antisera to species of

Neisseria other than gonococci cross react extensively with these anti
gens (33).
Two antigenic fractions of gonococcal endotoxin have been charac
terized which react in complement fixation and gel diffusion tests (38).
One fraction, "3", cross reacted extensively with other Neisseris (39,
42).

The other fraction, "a", demonstrated some specificity for the

gonococcus (39, 42).

Fraction "a" has not, however, been shown to be

any more reliable than the whole cell or protoplasmic antigens for use
in diagnostic assays for gonorrhea.
Gonococcal pili have been used in a radioimmunoassay by Buchanon
et al. (8) with some success.

Other investigators (50) have shown that

pili are highly strain specific, a finding which, if confirmed, would
limit the usefulness of pili in a diagnostic test.
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Gonococcal ribosomes have been used successfully in delayed hyper
sensitivity (DH) type skin tests with animals immunized with N. gonor
rhoeae (26).

Usefulness of delayed skin tests in diagnosis of gonococcal

infection in human patients has not been shown.
More recently a disrupted cell extract has been used in a radio
immunoassay for the detection of specific antibodies against the gonococcus in human sera (36).
tained with this antigen.

A high degree of specificity has been ob
In a study of sera from 382 patients, 90% were

correctly diagnosed, 5% were incorrectly diagnosed and 5% could not be
diagnosed as either positive or negative (36).

These results were equal

to or superior to results reported for the serological diagnosis of
gonorrhea ençloying pili antigens (8).
The objective of this research project was to characterize the
specific antigen contained in the disrupted cell extract and, if possible,
to purify the antigen from the crude extract.

The goal of characteriza

tion was to elucidate the chemical and physical nature of the gonococcal
specific antigen, to measure its biological properties and to test the
stability of the antigen to various treatments.

It was hoped that such

a study would increase the knowledge of specific antigens on the gonococcus and would lead to procedures for purification of the antigen.
Purification of the antigen would increase the specificity of the assay
for the diagnosis of gonococcal infection.
Several properties of the model system enqiloyed in this study
rendered efforts to characterize the antigen more difficult.

Perhaps

the greatest hindrance was that all work was performed with human sera
rather than antisera obtained from artificially immunized animals.

The
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human serum model required that the assay system had to be capable of
detecting very low antibody levels.

This eliminated gel precipitation

or flocculation assays as adjuncts to characterization procedures.

Also,

because of the low antibody titers and the extreme sensitivity required
of the assay, non-specific reactions in some cases overshadowed specific
reactions.

This created problems of interpretation of assay results.

However, because humans are the only species infected naturally by the
gonococcus (34) and because results from previous work with animal models
of gonococcal infection have not been shown to apply to the human system,
it was felt that despite the difficulties,

a study of the human system

was amply justified.
Another property of the system which was to be studied was the com
plex nature of the antigenic extract.

The specific antigen probably was

only a fraction of the crude extract.

Non-specific antigens in the ex

tract could react with antibodies in the human sera and, thus, affect
the assay results.

If such non-specific reactions occurred it would be

difficult to know if an experimentally determined characteristic was a
property of the specific gonococcal fraction or was a property of other
material contained in the extract.

A possible way to overcome this pro

blem would have been to purify the specific gonococcal antigen before
attempting to characterize it.

This approach was not taken, however,

because it was felt that attempts to purify an unknown entity could
easily turn out to be a fruitless, time-consuming endeavor.

Therefore,

an inhibition assay, which allowed study of the specific antigen in the
presence of other materials, was employed for most determinations of
antigenic activity.

In some cases a direct assay of antigenic activity
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also was enç)loyed to add confidence to interpretation of results obtained
with the inhibition assay.
In order to characterize the gonococcal specific antigen it was
necessary to determine the chemical, physical, and biological properties
of the antigenic extract.

Also, it was necessary to study the relation

ship of these properties to gonococcal specific antigenic activity.
Finally, it was hoped that the experimentally determined characteristics
could be used to propose a model for the structure of the gonococcal
specific antigen.

CHAPTER II

MATERIALS AND METHODS

Gonococcal strains

Neisseria gonorrhoeae strain F62 was obtained from Dr. D. S. Kellogg,
Jr., Center for Disease Control, Atlanta, GA.

In addition, a strain

freshly isolated from an infected patient was obtained from the Infec
tious Disease Center, Missoula, MT, and designated strain IDC.

Maintenance and cultivation of organisms

Strain F62 organisms were stored in lyophilized form.

Both strain

F62 and strain IDC were stored for short periods (up to 4 weeks) at
-20*C in a special freezing medium containing Eagle minimum essential
medium plus 20% glycerol, pH 7.0.
During periods of frequent use, the cultures were maintained on
GC Medium Agar Base (Difco, Detroit, MI.) supplemented with 1% IsoVitalex
(Bioquest, Cockeysville, MD.).

T1 phase colonies of strain F62 and T3

phase colonies of strain IDC were selected and transferred daily.

Plates

were incubated 18 h at 37°C in a candle extinction jar.
For extraction, cultures were grown in modified Thayer-Mart in broth
medium (62) containing 15 g proteose peptone #3 (Difco), 4 g K2HPO4,
0.1 g cornstarch, and 5 g NaCl in 1 1 deionized distilled water (DDW).
The pH was adjusted to 7.2 with HCl.
6

The medium was supplemented with
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sterile calf serum to 5% (v/v) prior to inoculation.

Scrapings from an

18 h plate culture were inoculated into one 1 broth in a wide bottom two 1
flask.

Cultures were gassed with a mixture of 83% N2, 7% O2, and 10%

CO2 and incubated 24 or 48 h at 37*C with gentle rotation.

After incu

bation, each broth culture routinely was checked for purity by Gram
staining and plating.

Extraction procedures were initiated if no con

tamination was revealed by the Gram stain.

Plates were examined the

following day as a check on purity, and to determine the distribution of
gonococcal colony types.

Preparation of antigenic extracts

Cells from a 24 or 48 h broth culture were harvested by centrifugation and washed with 0.1 M Tris-HCl buffer, pH 8.0 (Tris).

The washed

cells from one 1 of medium were suspended in 25 ml of 2% sodium deoxycholate in Tris and allowed to stand at room temperature for 1.5 h.

The

disrupted cells were then centrifuged for 30 min at 27,000 X£ and 25*C.
The antigen was precipitated by decanting the supernatant fluid (SF)
into six volumes of 95% ethanol and allowing the precipitate to develop
overnight at room tençerature.
winding onto a wooden stick.

Strands of nucleic acid were removed by

Additional nucleic acid floccules were re

moved from the precipitate by filtration onto gauze.

The filtrate was

centrifuged at 1500 X £ for 30 min to separate out an insoluble fraction.
This pellet was suspended in 15 ml distilled water and recentrifuged at
27,000 X £ for 30 min to sediment a particulate fraction.

The super

natant fluid from the final centrifugation (containing the soluble anti
gen) was transferred to dialysis tubing and dialyzed for 5 days against
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daily changes of distilled water at 4°C.
was lyophilized.

After dialysis, the antigen

The product of this extraction procedure was designated

GCE.

Labeling of antigens

Several batches of GCE were labeled with
method of Gruber and Wright (20).

(irvine, CA) by the

Briefly, in this technique, a modified

Conway microdiffusion cell was made by cutting the top from a 1 dram vial
and placing the bottom half into a 125 ml Erlenmeyer flask; this formed
a separate inner chamber.
into the outer chamber.

The antigen solution to be labeled was pipetted

Then 0.2 ml of 0.002 M KI and 500 y Ci of

were added to the inner chamber.
vaccine stopper.

The flask was sealed with a skirt-type

Two-tenths ml of a 1/20 dilution of 0.27 M Na2Cr20y in

36 N H2SO4 was added to the inner chamber with a syringe and four inch
needle.

The flask was allowed to sit at room temperature for 1 to 3 h

with occasional gentle shaking.

The labeled antigen (GCE*) was separated

from the free 125i by dialysis against four daily changes of one 1 PBS.
All work was performed behind lead shielding.

Human serum source

Two human serum pools were employed.

One pool was prepared by mix

ing, in varying proportions, sera obtained from a local blood bank so
that when it was reacted with the gonococcal antigen in the radioimmuno
assay, it gave an activity ratio similar to that obtained with serum
samples from anatomically virginal females; it was designated VI.
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A positive serum pool was obtained from blood drawn from a 24 year
old Caucasian female.

This individual had been culturally positive for

N. gonorrhoeae 3 times and had been treated for gonorrhea two additional
times.

The patient was in average general health.

This pool of serum

was designated R-65.

Preparation of anti-immunoglobulin

Antiserum to human gamma globulin was prepared by injecting New
Zealand white rabbits on day 1 with 4 mg of Cohn Fraction II of pooled
human sera (Cutter Laboratories, Berkeley, CA), as follows: 1 mg intra
venously suspended in saline, 1 mg intraperitoneally suspended in saline,
and 2 mg intramuscularly suspended in an equal volume Conq)lete Freund
Adjuvant (Difco, Detroit, MI).

The rabbits were then injected intra

muscularly at weekly intervals with 2 mg protein in Conç)lete Freund
Adjuvant.
week.

Rabbits were bled by cardiac puncture at the end of the fifth

Following the initial bleeding, the rabbits were alternately bled

and boosted at weekly intervals.

Radioimmunoassay

The reaction mixture for assaying the specific antigonococcal reac
tion (SAGR) of the serum samples consisted of 0.5 ml of phosphate buf
fered saline (0.15 M NaCl, 0.0033 M PO^; pH 7.2) (PBS), 20 y1 human
serum, and 10 yl labeled antigen solution containing 1 yg GCE* in a 12 ml
conical centrifuge tube.

Following an initial incubation, precipitation

was induced by the addition of anti-human immunoglobulin.

Eppendorf

microliter pipets (Brinkman Instruments, Inc., Westbury, NY) were employed
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to disperse the serum and the antigen solutions.

The assay procedure is

outlined in Figure 1.

Inhibition assay

The inhibition assay was used to measure the effects of various
treatments on GCE.

Each inhibition assay included nine reaction mixtures:

An uninhibited control, four standards containing untreated GCE, and four
experimental tubes containing treated GCE.

The assay was set up accord

ing to the protocol outlined in Figure 2 and assayed as described in
Figure 3.

The activity ratios were calculated for each reaction mixture.

If the unlabeled GCE inhibited the binding of GCE* there would be a de
crease in the value of the activity ratio.

Inhibition curves were ob

tained from a plot of the values of the activity ratios against the log
of the amounts of inhibitor added.
In order to compare inhibition curves from different assays, the
inhibition curves were normalized.

This normalization was accomplished

by designating the activity ratio of the uninhibited control as 100% of
control binding and designating the lowest activity ratio obtained by
inhibition with untreated GCE as 0% of control binding.

The values of

the remaining activity ratios were graphed proportionally as percentage
values.

The experimental curve, thus, was plotted relative to the stan

dard curve.

This procedure always resulted in a standard curve showing

a decrease in percent of control binding from 100% to 0% as the amount
of untreated GCE inhibitor was increased incrementally from 0.0 yg to
10.0 yg.

The amount of inhibitor added which resulted in a 50% inhibi

tion of control binding was determined by visual inspection of the graph

Figure 1.

Specific antigonococcal reaction (SAGR)
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10 pi GCE* (^25J labeled GCE) added to 20 yl human serum in 0.5 ml PBS
and mixed gently
+
Incubate 30 min, 37"C
40.25 ml rabbit anti-human immunoglobulin added
4Incubate 30 min, 37®C and 18 h, 4°C
+
Separate precipitate (PPT) from supernatant fluid (SF) by centrifugation
at 1000 X
30 min, 4'C
4
PPT washed 3X in ice-cold PBS; SF decanted and 100 yl saved for analysis
+
PPT and 100 yl SF counted in a manual crystal scintillation unit at a
voltage in the Geiger-MOller region (1064 volts).
4The ratio of bound (precipitated) to a total of bound plus unbound anti
gen was determined form the following formula:
Activity ratio =
Activity ratio

cpm PPT - Background (BKG)
ppT _ cpm BKG + cpm 100 yl SF - cpm BKG

Figure 2.

Protocol for inhibition assays.
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Standards*
Tube #
Human serum, ul

Experimental^

12345678
20

20

20

20

20

20

20

20

Untreated GCE, pg

0.2

1.0

5.0 10.0

Treated GCE, yg

—

—

—

PBS

Volume of all tubes adjusted to 0.52 ml

—

0.2

1.0

5.0 10.0

Assayed as outlined in Figure 3.

^Untreated GCE employed in preparation of standard curve
^Treated GCE

Control
9
20

Figure 3. Assay procedure for inhibition
of specific antigonococcal reaction.
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Inhibitor pre-incubated 30 min, 37°C with 20 ml human serum
+
10 yl GCE* (IZS; labelled GCE) added
i
Incubate 30 min at 37*C

0.25 ml rabbit anti-human immunoglobulin added
4Incubate 30 min at 37*C and 18 h

at 4°C

+
Separate PPT from SF by centrifugation at 1000 X £ for 30 min at 4*C.

+
PPT washed 3X in ice-cold PBS; SF decanted and 100 pi saved for analysis.

PPT and 100 yl SF counted in a manual crystal scintillation unit at a
voltage in the Geiger-Miiller region (1060 volts).

The ratio of bound (precipitated) to a total of bound plus unbound anti
gen was determined from the following formula:
Activity ratio =
Activity ratio

cpm in PPT - Background (BKG)
ppT - cpm BKG + cpm in SF - cpm BKG
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and designated the IA50.

By the nature of the normalization procedure

the value of the IA50 of the standard curves was approximately 1.0 yg.
The value of the IA50 of the experimental curves varied widely depending
on the treatment performed on GCE.

The capacity of treated GCE to inhi

bit SAGR was expressed as a percent of the capacity of untreated GCE to
inhibit SAGR according to the following formula:
% of standard inhibition = 100 X FLASP untreated GCEI^
tiAso treated GCE J
The percentage value obtained from this formula was a measure of the
effect of the treatment on GCE.

Nitrogen determination

Organic nitrogen was converted to inorganic nitrogen by Kjeldahl
digestion (cf. 27). Inorganic nitrogen was estimated by the Messier
reaction as modified by Johnson (25a).

Ammonium sulfate nitrogen stan

dards and reagent blanks were carried through the entire procedure.
Protein content was calculated assuming 16% nitrogen.

Protein determination

Protein content of GCE was estimated by the method of Lowry et ai.
cf. 27).

Solutions of 2% Na^COg in 0.10 N NaOHandO.5% CuSOj-SH^O in

1% sodium tartrate were prepared.

Subsequently, 1 ml of the copper

solution was added to 50 ml of the Na2C03-Na0H just before the reagent
was to be used.
(10-100 lig).

Then 2.5 ml of this reagent was added to 0.5 ml protein

After 10 min at room temperature, 0.25 ml of Folin reagent

diluted to 1 N was added with vigorous mixing.

Reagent blanks and bovine
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serum albumin standards were treated similarly.

After 30 min at room

tençerature the solutions were read against a reagent blank on a Beckman
DU-2 spectrophotometer at a wavelength of 650 nm.

DNA determination

DNA content of GCE was estimated by the diphenylamine reaction
(cf. 27).

Diphenyleunine reagent was prepared by dissolving 1.5 g diphen-

ylamine in 100 ml glacial acetic acid followed by the addition of 1.5 ml
concentrated H2SO4.

Then 0.10 ml aqueous acetaldehyde (16 mg/ml) was

added per 20 ml of the above solution.

Two ml of this latter reagent

was mixed with 1 ml DNA (10-200 yg) and the tubes were heated for 10 min
in a boiling water bath.

Blanks and DNA standards (calf thymus DNA,

highly polymerized, Sigma Chemical Conqjany, St. Louis MO) were treated
similarly.

Tubes were cooled and read at 600 nm on a Beckman DU-2 spec

trophotometer against a reagent blank.

DNA content was determined by

interpolation from a standard curve prepared by plotting absorbancies
obtained with varying amounts of a standard DNA solution.

RNA determination

RNA content of GCE was estimated by the orcinol reaction for pentose
determination (cf. 27).

The orcinol reagent was prepared by mixing 1

volume of a solution of 1.6 g orcinol in 100 ml H2O with 7.5 volumes of
21.6 N H2SO4.
(10-100 yg).

Two ml of this orcinol reagent was mixed with 1 ml RNA
The tubes were heated for 20 min in a boiling water bath.

Reagent blanks and RNA standards (yeast RNA, Schwartz/Mann, Orangeburg,
NY) were treated similarly.

The tubes were cooled and read at 640 nm
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against a reagent blank on a Beckman DU-2 spectrophotometer.

RNA content

was determined by interpolation from a standard curve prepared by plot
ting absorbancies obtained with varying amounts of a standard RNA solu
tion.

Ultraviolet absorption spectra

The absorbance of 100 yg/ml samples of GCE were measured in a Beckman
DU-2 spectrophotometer at wavelengths of 220 nm to 320 nm.

The 260/280

ratio was used to estimate protein content and nucleic acid content of
the antigen extractions according to the absorbance relationships deter
mined by Warburg and Christian (65).

Sephadex chromatography

Sephadex G-200 (Pharmacia Fine Chemicals, Inc., Piscataway, NJ) was
suspended in PBS and allowed to swell overnight.

The slurry was dearated

by vacuum and then packed in a 30 cm x 1 cm column.
(containing 25 ug GCE labeled with 125j
and eluted with PBS, pH 7.2.

A 0.25 ml sample

PBS) was layered on the column

One ml fractions were collected at a rate

of 0.5 ml/mg and analyzed for total radioactivity.

Fractions containing

2000 cpm/ml or over were assayed for reactivity with the standard positive
serum (R65).

Sucrose velocity gradient ultracentrifugation

Sucrose velocity gradient ultracentrifugation was used in an attempt
to separate components of the crude antigen extract.

A 10% to 50% dis

continuous sucrose gradient was prepared in 13 ml polyallomer tubes.
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Then 0.4 ml GCE* in 10% sucrose was layered on the top of the gradient.
Following ultracentrifugation in a Beckman L2-65B ultracentrifuge at
100,000 X £ for 16 h at 4®C in a Spinco type 65 rotor, 12-drop fractions
were collected from the bottom of the tubes and these fractions were
analyzed for total radioactivity.

Fractions containing 2000 cpm/ml or

over were dialyzed against PBS for 4 days and assayed for reactivity
with the standard positive serum.

Samples from each fraction were anal

yzed for sucrose concentration by the anthrone reaction (cf. 27].

Physical and chemical treatments

In experiments where the effects of the treatment on GCE were mea
sured by the inhibition assay treatments were performed on 20 yg GCE.
Following the treatment the volume was adjusted to 1 ml and divided into
samples containing 10, 5, 1, and 0.2 yg GCE.

Each sample was adjusted

to a final volume of 0.5 ml with PBS and assayed by the previously de
scribed inhibition assay (cf. Figure 2).
In some experiments treatments were performed on labeled GCE (GCE*).
In these experiments 20 yg GCE* was treated.

Following treatment the

volume was adjusted to 1.0 ml and 0.5 ml aliquots were assayed directly
for reactivity with the positive human serum.

Heat stability.

Twenty yg GCE in 1 ml PBS was heated in a boiling water

for 2 min or 1 h.

Other samples were heated at 56"C for 1 h and assayed

as described above (cf. Figure 2).

pH stability.

Twenty yg GCE in 20 yl PBS was incubated for 1 h at 23-

25*C with 0.25 ml 0.1 N HCl.

Following incubation the reaction mixture

was neutralized with 25 y eq NaOH and the volume was adjusted to 1.0 ml
with PBS.

The effects of the treatment were determined by the inhibition

assay (cf. Figure 2).

Stability to treatment with base was determined

similarly, incubating with 0.1 N NaOH and neutralizing with HCl.

Trypsin digestion.

Twenty yg GCE and 100 pg trypsin. Nutritional Bio-

chemicals Corporation, Cleveland, OH, (2X crystalline, 50% MgSO^), in
1 ml PBS were incubated overnight at 37°C.

The reaction was stopped by

boiling the samples for 2 min and assaying them as above (cf. Figure 2).
When the treatment was performed on labeled GCE (GCE*), the following
modifications were employed.

Twenty wg GCE* and 20 ug trypsin in 0.14 ml

PBS were incubated 3.5 h at 37*C.

The volume was adjusted to 1.0 ml and

the reaction was stopped by boiling for 2 min.

The effects of the treat

ment were measured by assaying 0.5 ml aliquots for reactivity with the
standard human serum.

Pronase digestion.

Pronase (B grade, Calbiochem, Los Angeles, CA)

treatment was performed in exactly the same manner as the trypsin diges
tion described above (cf. Figure 2).

Periodate oxidation.

Twenty yg GCE was incubated overnight in the dark

at room tençerature with 46 yg sodium meta periodate in 1 ml PBS.

The

reaction was stopped by the addition of 20 yg glycerol and assayed as
above (cf. Figure 2).

Deoxyribonuclease digestion. Twenty yg GCE was incubated 2 h at 37°C
with 20 yg DNase (Deoxyribonuclease 1, Crude, Sigma Chemical Company,
St. Louis, MO) in 0.25 ml PBS pH 5.5.

The pH was then adjusted to 7.2
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and the volume adjusted to 1 ml with 0.1 m tris buffer.

Activity was

assayed as above (cf. Figure 2).
When the treatment was performed on labeled GCE the following mod
ifications were employed.

Twenty yg GCE* and 20 yg DNase in 0.15 ml PBS

were incubated 3.5 h at 37*C.
with PBS pH 7.2.

The volume was then adjusted to 0.5 ml

Activity was assayed by reactivity with the standard

positive human serum.

Ribonuclease digestion.

Twenty yg GCE was incubated 2 h at 37°C with

20 yg RNase (Ribonuclease-A, Sigma Chemical Company, St. Louis, MO) in
0.25 ml PBS pH 5.5.

The volume was adjusted to 1 ml and the pH was ad

justed to 7.2 with 0.1 m tris HCl buffer.

Activity was assayed as above

(cf. Figure 2).
When the treatment was performed on labeled GCE the same modifica
tions as used in the DNase digestion were employed.

Saponification.
methanol.

Twenty yg GCE in 20 yl PBS was added to 0.23 ml absolute

To this was added 0.25 ml methanol containing 0.2 M KOH.

The

mixture was incubated 1 h at 23-25°C followed by neutralization with
0,5 m eq DowexSO. The mixture was mixed 15 seconds on a vortex mixer
the the Dowex beads were allowed to settle.
removed with a capillary pipet.

The antigen solution was

Saponified lipids were then extracted

by the addition of 0.5 ml ether and 0.5 ml water.

The tube was mixed

15 seconds on a vortex mixer and the phases separated by centrifugation
at 1000 X £ for 10 min at 4°C.

The ether phase was discarded and the

aqueous phase was dialyzed against twice daily changes of PBS for 2 days
at 4*C.

The effects of the treatment were measured by the inhibition

assay (cf. Figure 2).
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Electron microscopy

Heavy suspensions of whole cells of T1 phase F62 and T3 phase IDC
were obtained by washing the colonies from an 18-24 h plate culture with
distilled deionized water.

Samples of the cell suspensions were mixed

with an equal volume 3% (w/v) phosphotungstic acid pH 7.2.
this mixture was placed on a formvar coated grid.

A drop of

After allowing the

bacteria to settle on the grid, excess moisture was removed with a cap
illary pipet.

The grids were allowed to air dry and then observed and

photographed with a Zeiss EM9-S2 electron microscope (Carl Zeiss, West
Germany).

Biological tests

The pyrogenic responses of rabbits to intravenously administered
GCE and gcLPS were determined by standard procedures leading to deter
minations of FI40 (dose producing a fever index of 40 cmr) (47, 67).

To

obtain the FI40, groups of 4 rabbits were inoculated with graded doses
of pyrogen and the temperatures were recorded at intervals for a period
of 7 h.

The individual curves were plotted with 1°C and 1 h each allot

ted one inch.

For each animal the area included between the temperature

curve and the baseline was obtained in square centimeters by computer.
This area was called the fever index (FX).

The average FX, at each dose

level, was then plotted against the logarithm of the dose, and the FI^Q,
or that dose expected to give a FX of 40 cm^, was read from the graph.
Lethality for chick embryos was estimated as described previously
(47).

Embryos, after 11 days of incubation, were inoculated intraven

ously with doses contained in 0.1 ml.

In each test, ten embryos were
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inoculated with each of five graded doses, differing by five-fold.

The

results, after an additional 24 h of incubation, were used to calculate
the median lethal dose for chick embryos (CELD^Q) as described by Irwin
and Cheeseman (25).

Extraction of endotoxin from N. gonorrhoeae

A 48 h flask culture of N. gonorrhoeae was harvested by centrifugation at 1800 X ^ for 30 min at 4''C and washed once in cold PBS.

The

cells were resuspended in 50 ml DDW and an equal volume of 88% liquid
phenol (U.S.P., J. T. Baker Chemical Company, Phillipsburg, NJ) was
added.

The mixture was placed in a 65°C water bath and stirred until

the temperature reached 65°C and the phenol and aqueous phases homogen
ized.

Stirring was continued for another 30 min, and the solution was

distributed to glass centrifuge tubes, which were then chilled in an
ice bath overnight to allow the phases to separate.
trifuged at 4°C for 60 min at 1800 X g.

The tubes were cen-

The aqueous phases, after re

moval from the inter- and phenol-phases, were combined.

An equal volume

of water was added to the combined phenol and inter-phases and the ex
traction was repeated; the second aqueous phase was combined with the
first, and the phenol residues were discarded.

The aqueous phases were

dialyzed against running tap water at about 6°C for seven days and
against three daily changes of distilled water at 4°C.

Sufficient sodium

acetate was added to the aqueous phases to bring the concentration to
0.15 M:

the solution was cooled and 95% ethanol was added at 4*C, drop-

wise with stirring, to bring the alcohol concentration to 68%.

After

allowing the suspension to stand overnight at 4°C, the precipitate was
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collected by centrifugation at 1800 X £ for 30 min.
dissolved in distilled water and lyophilized.
this method was designated gcLPS.

The precipitate was

The endotoxin produced by

The above procedure was a modification

of the method of Westphal et ai. (cf. 56).

CHAPTER III

RESULTS

Chemical and biological analyses of GCE

A radioimmunoassay for the diagnosis of gonorrhea has been developed
recently (36).

The antigen used in this assay was a crude extract of

whole cells of Neisseria gonorrhoeae strain F62; this extract contained
at lease one antigenic fraction specific for the gonococcus.

The next

step in refining the assay was to characterize the antigen in the extract
with the ultimate aim of purifying the antigenic fraction.

Also this

could increase both understanding of the antigenicity of the gonococcus
and specificity of the seroassay.
As a first step in the characterization, a limited series of chemi
cal analyses were performed on various preparations.

The analyses were,

of necessity, limited; the yield from a 1 liter culture was only 1 to
2 mg GCE.

It was decided that a 100 yg sample was the maximum amount

which would be used for any given assay in order to carry out the maxi
mal number of tests on a single preparation.

If a given substance con

stituted less than 1% of the preparation, then the assay would have to
be sensitive to amounts of less than 1 yg in order to detect the sub
stance.
As a working hypothesis, based on the extraction procedure and
some preliminary results (Rudbach, unpublished data), it was felt that
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the gonococcal specific antigen might be a protoplasmic polypeptide,
glycoprotein, or nucleoprotein.

However, the possibilities existed that

gonococcal endotoxin or pili could have contributed to the specific anti
genic reactivity.
The first analytical data obtained were UV absorption spectra
(from 220 nm to 320 nm) on several GCE preparations (Figure 4).

Protein

and nucleic acid were estimated from a nomograph based on the relation
ships described by Warburg and Christian (65).

It was found that GCE

contained from 80% to 90% protein with substantial nucleic acid contam
ination (Table 1).

Several preparations were analyzed for total nitogen

(cf. 27) and protein was estimated assuming 16% nitrogen (Table 1).

By

this method it was found that GCE contained from 57% to 87% protein.
More specific assays were then enqjloyed for the estimation of protein
and nucleic acid.

The results are summarized in Table 1.

Protein was

estimated by the Lowry method (cf. 27) to be from 40% to 68%.

RNA con

tent was estimated to be from 6.4% to 37% by the orcinol reaction (cf. 27).
DNA content was estimated from the diphenylamine reaction (cf. 27) to be
less than 1.0% in all preparations.
Since endotoxin (LPS) is a major component in cell walls of gram
negative bacteria, it was necessary to determine LPS content of GCE.
The easiest and most sensitive way to do this was through a comparison
of quantitative bioassays for endotoxin performed on GCE and on LPS ex
tracted from the gonococcus.

A phenol-water extract of gonococci was

prepared by a modification of the method of Westphal et al. (cf. 56).
This endotoxin extract was designated gcLPS.

Both GCE and gcLPS were

assayed for endotoxic activities by the quantitative capacity to cause

Figure 4.

UV absorption curves of two GCE preparations

\Gc4
0)
u

c

8
<

30

Table 1.

Chemical analyses of various GCE preparations

Protein

RNA

DNA

Total Nucleic Acid

%

%

%

%

gc 2

120.0*
57C

ndb

nd

18.0*

gc 4

90.0*
86.9^

nd

nd

51.0*

gc 11

70.0*

nd

nd

55.0*

gc 22

68.Od

6.4®

<1.0^

6.48

gc 26

40.Od

26.0®

<1.0^

26.08

gc 31

45.2^

37.8®

<1.0^

37.8®

GCE

^Protein and nucleic acid content estimated by UV absorption,
^nd = not done.
^Protein estimated from nitrogen content determined by
Nessler Nitrogen Analysis.
^Protein estimated by Lowry method.
®RNA estimated by reaction with orcinol reagent.

.P

DNA estimated by reaction with diphenylamine.

^Nucleic acid as RNA.
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fever in rabbits and to kill chick embryos (47).
ties are tabulated in Table 2.
activity.

The biological activi

Both preparations demonstrated endotoxic

However, gcLPS was 20 fold more potent in the CELD^Q and

nearly 10 fold more potent in the FI40 than GCE when compared on a weight
basis.

From these results it can be estimated that GCE contained no more

than 15% LPS.
Taken as a whole, the results of chemical and biological analyses
of GCE indicated several things.

GCE was mostly protein but there were

substantial amounts of RNA in some preparations.

GCE had endotoxic acti

vity, but endotoxin was not the major constituent of GCE.

These facts

were taken into account in subsequent experiments which were designed to
characterize the specific gonococcal antigenic fraction of GCE.

Ability of GCE to inhibit SAGR

Previous studies (W. R. Cross and J. A. Rudbach, unpublished data)
have established that the concentrations of GCE* and anti-gonococcal
human serum employed in SAGR fell in the equivalence zone or region of
slight antigen excess.

Under these conditions all available antibody

combining sites are bound by antigen.

Addition of non-radioactive GCE,

therefore, would compete with radiolabeled GCE (GCE*) for antibody com
bining sites.

The ratio of bound-GCE* to unbound-GCE* would be directly

proportional to the amount of cold GCE added to the reaction mixture.
It should be emphasized that conditions were established for SAGR so
that all the human immunoglobulin was precipitated by the addition of
rabbit anti-human immunoglobulin.

It has been shown (19) that if all

anitbody was precipitated, the fraction of labeled antigen precipiated
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Table 2.

Biological activities of GCE
and gonococcal LPS.

GCE

LPS

FI40*

3.5

pg

CELDisob

0.62 yg

% LPS in GCE

yg

14.3C

0.03 yg

4.8^

0.5

&FI40 = yg material required to produce 40 cm^ under
fever response curve. This was determined as described
in Materials and Methods.
''Mean lethal dose (yg) for chick embryos.
^Calculated by:
% LPS = 100 X

Flan LPS
FI40 GCE

^Calculated by:
% LPS = 100 X

CELD50 LPS
CELD50 GCEJ
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would decrease in linear fashion if plotted against the log of the con
centration of unlabeled inhibitor added.
Figure 5 shows a series of inhibition curves for a variety of GCE*
and GCE preparations.

In this figure the activity ratios, which are a

measure of the fraction of GCE* precipitated, are plotted against the
log of the amount GCE added.

There is considerable scattering of points

and variation from preparation to preparation and assay to assay.

In

order to compare results obtained with different GCE and GCE* prepara
tions, some means of standardization was needed.

The means selected was

to consider each standard curve separately and express each activity
ratio as a percent of the activity ratio obtained with the uninhibited
control for that single experiment.

The zero point was defined as the

lowest activity ratio obtained by inhibition with GCE.

This was usually,

but not always, the activity ratio obtained with 10 wg GCE added as in
hibitor.

Figure 6 shows the same curves from Figure 5 plotted in this

"normalized" manner.
The amount of GCE added which gave 50% inhibition of control binding
was designated the 50% inhibition point, or the IA^Q.
IA50

The value of the

of the standard curves was approximately 1 yg.
Once it was established that GCE could be used to inhibit SAGR and

the results were standardized to allow comparisons, treatments could be
performed on GCE and the effects of these treatments could be measured
as a change in the capacity of the treated GCE to inhibit SAGR as com
pared to untreated GCE.

In every experiment a standard curve was pre

pared by assaying untreated GCE.
ative to the standard curve.

The experimental curve was plotted rel

The lAgg of each was determined from

Figure 5. Capacity of GCE to inhibit SAGR. Activity ratios are plotted
against amount GCE added. Standard curves from 9 different experiments
shown. Curves with the same symbol represent assays employing the same
GCE and GCE* preparations. The same standard human positive serum was
used throughout.

Activity Ratio

W
ui

Figure 6. Standardization of inhibition curves. Nine inhibition curves
plotted as a percentage of control binding. Standard curves from 9 dif
ferent experiments are shown. Curves with the same symbol represent
assays employing the same GCE and GCE* preparations. The same standard
human positive serum was used throughout.

/o of control binding
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inspection and the activity of the treated GCE was then expressed as a
percentage of the activity of the untreated GCE.

Effect of heat treatment on the capacity of GCE to inhibit SAGR

It is known that most protein antigens are denatured by heating at
56°C 30 min or by boiling (cf. 1), whereas other antigens such as lipopolysaccharides (cf. 48) and glycoproteins (cf. 22) are resistant to heat
treatment.

When GCE was heated at 56®C, 1 h or boiled 2 min there was a

slight increase or no change in ability to inhibit SAGR.

Longer heating

in a boiling water bath resulted in substantial loss of ability to inhi
bit SAGR (Figures 7 and 8).

The IA.50 values of controls were 1.57 yg to

1.0 ug; after heating at 56*C for 1 h or boiling 2 min, the IA50 values
were reduced to 0.2 to 0.7 yg respectively, an increase in activity of
up to 785% of the control.

If GCE was heated in a boiling water bath for

longer than 2 min, the IA50 increased to 3.3 to 4.0 yg which represented
a decrease in activity of 70% (Table 3).
The biphasic nature of the effect of heating was found to be repro
ducible.

It could be that moderate heating caused an increase in solu

bility or caused some degree of disaggregation of subunits of GCE,
therefore increasing activity.

Prolonged heating at high temperatures

might have caused denaturation of the antigen.

These results were not

inconsistent with the hypothesis that the specific fraction of GCE was a
low molecular weight polypeptide.

Effect of acid and alkali treatment on capacity of GCE to inhibit SAGR

It was necessary to obtain knowledge of the stability of GCE under
various conditions of acidity and alkalinity as background information

Figure 7. Effect of heat treatment on quantitative capacity of GCE to
inhibit SAGR. Untreated GCE, A; GCE boiled 1 hr, B; GCE heated 56°C,
1 hr, C.
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Figure 8. Effect of boiling on quantitative capacity of GCE to inhibit
SAGR. Untreated GCE, A; GCE boiled 5 ndn, B; GCE boiled 2 min, C.
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before designing other experiments.

Because many of the subsequent pro

cedures involved incubating GCE at varying pH, it was important to know
what effects acid and alkali had on GCE so that these effects could be
taken into account in interpreting other data.
When GCE was subjected to treatment with 0.1 N HCl for 1 h at 23°C,
there was a moderate increase in activity (Figure 9), whereas treatment
with 0.1 N NaOH had a negligible effect in either direction.

The IA^Q

was reduced from 1.3 yg to 0.48 vg by acid treatment, which calculated
as an increase in activity to 273% of the control.
The increase in activity due to acid treatment might be interpreted
as an indication that more sites had been made available for binding by
specific antibody.

The low pH achieved in this experiment was well below

the isoelectric point of most proteins (31).
molecule has the same net charge.

They would, therefore, repel each

other preventing aggregation (31).
immediately

At this pH each individual

Since the preparations were assayed

following neutralization, it is likely that a larger frac

tion of subunits of the treated GCE would exist in the disaggregrated
form than would the subunits of untreated GCE.
The results of these experiments also showed that GCE was stable to
treatment with 0.1 N acid or alkali.

Effect of periodate oxidation on capacity of GCE to inhibit SAGR

This experiment was designed to determine whether or not a carbo
hydrate determinant was important for the specific antigenic activity of
GCE.

Periodate is known to cleave sugars between adjacent hydroxyls

(cf. 5).

Figure 9. Effect of pH on quantitative capacity of GCE to inhibit SAGR.
Untreated GCE, A; 0.1 m NaOH treated GCE, B; O.lmHCl treated GCE, C.
Treatments were for 1 h at 25°C.
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Oxidation with periodate reduced significantly the capacity of GCE
to inhibit SAGR (Figure 10).

The IAgo was increased from 1.5 yg for un

treated GCE to 4.0 yg for periodate oxidized GCE (Table 3), a decrease
in activity to 37.5% of the control.
sensitive to periodate oxidation.

These results showed that GCE was

However, it is know that periodate

can effect some changes in molecules other than sugars (cf. 5).

Effect of saponification on the capacity of GCE to inhibit SAGR

If a lipid moiety were important in the specific antigenic activity
of GCE, this might be detected by a decrease in activity caused by sapon
ification.

KOH in methanol is known to hydrolyze the ester linkage of

ester-bound fatty acids (22, 31).

The fatty acids which are soluble in

organic solvents would be removed by ether extraction.

In this experi

ment the control was GCE treated with methanol alone and extracted with
ether.
There was an increase in activity caused by saponification which is
not easily explained (Figure 11).

The effect was not due to the methanol

of ether extraction, since the lAgQ of the control was similar to the
lAgQ of other assays with untreated GCE (Table 3).
From these results it appeared, however, that there were no fatty
acid esters essential to the antigenicity of GCE.

Effect of enzymatic digestion on the capacity of GCE to inhibit SAGR

The next series of experiments was designed to explore more fully
the chemical nature of the moieties contributing to the antigenic acti
vity of GCE.

Enzymes specific for different classes of biological

Figure 10. Effect of periodate oxidation on quantitative capacity of
GCE to inhibit SAGR. Untreated GCE, A; Periodate oxidized GCE, B.
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Figure 11. Effect of saponification on quantitative capacity of GCE to
inhibit SAGR. GCE treated with 0.2 N KOH in methyl alcohol; cleaved
fatty acids were extracted with ether. Control was GCE treated with
methanol and extracted with ether. Control, A; Saponified GCE, B.
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Table 3. Summary of effects of various physical and chemical
treatments on quantitative capacity of GCE to inhibit SAGR.

Experiment #

Treatment

lAsO (Pg)*
Treated

Untreated

% of standard
inhibition

1

0.1 M HCl

0.48

1.30

270.8

2

0.1 M NaOH

1.40

1.30

92.8

3

0.2 M KOHMethanol

0.42

1.15

273.8

4

Periodate

4.00

1.50

37.5

5

56*C, 1 h

0.20

1.57

785.0

6

100*C, 1 h

4.00

1.57

39.2

7

100*C, 2 min

0.70

1.00

142.9

8

100"C, 5 min

3.30

1.00

30.3

^lAso = amount GCE required to achieve 50% inhibition of SAGR
of standard inhibition = lOOX

lAso untreated GCEl
IA50 treated GCE J
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molecules were employed.

A series of controls was carried through the

entire procedure for each assay containing the enzyme, but no GCE.

These

controls (results not shown) indicated that the enzymes alone had no
effects on SAGR.

Proteolytic enzymes were inactivated by boiling for

2 min following digestion.
DNase and RNase digestion had little effect on the capacity of GCE
to inhibit SAGR (Figure 12).

However, if the DNase was not inactivated

before addition of the preparation to the antibody, some inhibition was
noted (Figure 13). It was felt that this effect might have been due to
proteases contaminating the crude DNase preparation.

It can be seen from

the summary on Table 4 that the IA50 of both nuclease treated GCE and
untreated GCE are similar in all cases but one.
When GCE was digested with a proteolytic enzyme, considerable inactivation was noted.

Trypsin-treated GCE was much less able to inhibit

SAGR than untreated GCE (Figure 14).

The lAgg for trypsin treated GCE

was 3 yg compared with an lAgg of 1.0 yg for untreated GCE, which calcu
lated a decrease in activity of 67% (Table 4).
These results showed that GCE was resistant to ribonuclease diges
tion and deoxyribonuclease digestion, but was sensitive to trypsin
digestion.

Effect of enzyme digestion of GCE* on SAGR

Next to be performed was a direct assay on the susceptibility of
GCE to enzymatic digestion.

It was felt that direct treatment of radio

labeled GCE (GCE*) might provide results more easily interpretable than
results from the inhibition assays.

An additional set of controls was

Figure 12. Effect of nuclease digestion on quantitative capacity of
GCE to inhibit SAGR L. Untreated GCE, A; DNase digested GCE, B; RNase
digested GCE, C. Enzymes were heat inactivated by boiling 2 min fol
lowing digestion.
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Figure 13, Effect of nuclease digestion on quantitative capacity of GCE
to inhibit SAGR II. Untreated GCE, A; DNase digested GCE, B; RNase di
gested GCE, C. Enzymes were not inactivated following digestion.
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Figure 14. Effect of trypsin digestion on quantitative capacity of GCE
to inhibit SAGR. Untreated GCE, A; trypsin treated GCE, B.
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Table 4. Summary of effects of enzyme digestion on
quantitative capacity of GCE to inhibit SAGR.

Experiment #

Treatment

IA50 (wg)*
Treated

Untreated

% of standard
inhibition^

1

DNase

2.1

1.7

81.0

2

DNase

4.5

2.1

46.7

3

RNase

2.6

2.1

80.8

4

RNase

1.5

1.7

113.3

5

Trypsin

3.0

1.0

33.3

6

None

-

1.0

100.0

^lAso = amount GCE required to achieve 50% inhibition of SAGR.
of standard inhibition = 100 X ^^50 untreated GCE
( IA50 treated GCE
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included for the proteolytic enzymes in which the GCE* was not added un
til after heat inactivation of the enzyme.
When nuclease digestion was carried out on GCE* it was found that
RNase had little effect, and DNase reduced the activity by 24% (to 76%
of the control) (Table 5).
Trypsin and pronase were also employed in the digestion of GCE*
(Table 5).

The activity ratios were significantly reduced by trypsin

and pronase digestion, to as low as 38.7% of the control.

The enzyme

controls indicated that the heat inactivated proteolytic enzymes re
tained some capacity to reduce the activity of GCE*.

This effect was

probably due to incomplete inactivation of the enzymes.
The results of these experiments again showed that GCE* was resis
tant to nuclease digestion but highly susceptible to digestion by pro
teolytic enzymes.

Separation of GCE* components by molecular sieving on SephadexG-200

This experiment was designed to separate components of GCE on the
basis of molecular volume.

Sephadex G-200 excludes globular molecules

of molecular weight greater than 800,000 daltons while molecules of lesser
molecular weight are retained by the gel matrix and their flow through
the column is impeded.
Figure 15 shows the results of molecular sieving of GCE* on Sephadex
G-200.

It can be seen from the total radioactivity profile that GCE* was

separated into 3 major fractions.

When the fractions were assayed dir

ectly in SAGR, it was found that there was a specific activity peak
coinciding with the peak eluted with the void volume.

This suggested

Figure 15. Separation of GCE components by molecular sieving on
Sephadex G-200.
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that the active fraction of GCE existed in a high molecular weight form.
It was also noted that approximately 30% of the total cpm added to the
column could not be eluted.

Fractionation of GCE* by sucrose velocity gradient ultracentrifugation

Velocity gradient ultracentrifugation is another method of separat
ing molecules on the basis of size and shape.

High molecular weight,

globular molecules sediment at a greater rate than do low molecular weight
molecules.

A 20 yg sample of GCE* was centrifuged at 100,000 x £ for 16 h

on a discontinuous gradient of 10% to 50% sucrose.
Figure 16 depicts the results of fractionation of GCE* by sucrose
velocity gradient ultracentrifugation.

Although little separation was

detected in the total cpm profile, when the fractions were assayed by
SAGR, two areas of high antigenic
extreme of the gradient.

reactivity were found, one at each

This suggested either that the active fraction

of GCE existed in an aggregated, high molecular weight form and as low
molecular weight subunites, or that there were two distinct, active frac
tions, one of high molecular weight and one of low molecular weight.

Comparison of the capacities of GCE and gcLPS to inhibit SAGR

The biological studies previously described in this paper showed
that GCE contained no more than 10% LPS.

It was possible that this small

LPS component was responsible for the specific activity of GCE.

If this

were the case then purified gonococcal LPS would be able to inhibit SAGR
to a greater extent than could GCE.
signed to test this possibility.

The following experiment was de
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Figure 17 shows inhibition curves for GCE and gcLPS.
each is shown in Table 6.

The IA50 for

The lAgg for the LPS preparation was 10 fold

greater than the lAgg of GCE.

If the major antigenic component of GCE

were LPS, it would be expected that the LPS preparation would have approx
imately a 10 fold lower lAgg than GCE.

Since the reverse was true, it

could be assumed that the antigenic component specific for the gonococcus
in GCE was not LPS.

Comparison of the capacities of "T1 phase" GCE and "T3 phase" GCE
to inhibit SAGR

The following experiments were designed to investigate whether or
not the specific fraction of GCE was unique to virulent phases of gonococci.

Four colony types of N. gonorrhoeae have been described by

Kellogg, et ai. (28).

Two types (T1 and T2) are virulent and two types

(T3 and T4) are avirulent (28).

The most obvious difference among the

bacteria contained in these different types of colonies is that colony
types T1 and T2 contain piliated organisms whereas colony types T3 and T4
contain nonpiliated organisms (25, 52, 60).

These characteristics were

confirmed by electron microscopy (Figure 18) for the organisms used in
this study.
GCE from T1 phase gonococci and GCE from T3 phase gonococci (T3-GCE)
were compared in their ability to inhibit SAGR.
tion studies are shown in Figure 19 and Table 6.
10.0 yg compared to 0.46 yg for GCE.
of the activity of GCE.

The results of inhibi
The lAgQ of T3-GCE was

The activity of T3-GCE was only 5%

These results indicated that the specific com

ponent of GCE was not found in T3 phase gonococci and was, therefore,
probably associated with virulent gonococci.

Figure 16. Separation of GCE components by sucrose density gradient
ultracentrifugation.
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Figure 17. Comparison of capacities of GCE and gcLPS extract of T1
phase gonococci to quantitatively inhibit SAGR. GCE, A; gcLPS, B.

À of control binding

(Û

o-

ui

Figure 18. Electron micrographs of gonococci from T1 and T3 colony
types. Plates A and B show gonococci from T1 colonies; note presence
of pili. X 24,000. Plate C shows gonococci from a T3 colony; note
absence of pili. X 24,000.
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Figure 19. Comparison of T1 phase GCE with T3 phase GCE on quantita
tive capacity to inhibit SAGR. T1 phase GCE, A; T3 phase GCE, B.
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Table 5.

Experiment #

Siamnary of effects of enzyme digestion of GCE*& on SAGR.

Treatment

Activity ratio^
Treated

Untreated

% of control*'

1

DNase

0.633

0.831

76.2

2

DNase

0.633

0.819

77.3

3

RNase

0.792

0.762

103.9

4

RNase

0.789

0.880

89.7

5

Trypsin

9.318

0.822

38.7

6

Trypsin control^ 0.628

0.822

76.4

7

Pronase

0.328

0.822

39.9

8

Pronase control^ 0.656

0.822

79.8

9

None

0.822

100.0

accE* = 125i labelled GCE.
^Activity ratio =

cpm in ppt - background (BKG) cpm
cpm in ppt - cpm BKG + cpm in 100 yl SF - cpm BKG

H of control = 100 X
^Trypsin and pronase control: Enzymes incubated in saline followed
by boiling 2 min prior to addition of GCE*.
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Table 6. Comparative ability of GCE, T3 Phase GCE,
and gcLPS extract of T1 Phase gonococci to
quantitatively inhibit SAGR.

IA50 W*

relative activity^

gcLPS

6.00

10.8

GCE

0.65

100.0

10.00

4.6

0.46

100.0

inhibitor tested

"T3 Phase" GCE
GCE

^lAgQ - amount of extract required to achieve 50% inhibition
of SAGR.
,
( lAso GCE I
^Relative activity = 100 X [ia^q sample]

CHAPTER IV

DISCUSSION

In this study an antigen, specific for Neisseria gonorrhoeae which
was contained in a crude gonococcal extract, was characterized by a
variety of techniques.

The crude extract was found to contain mostly

protein and substantial amounts of RNA in some preparations.

The ex

tract was toxic for chick embryos and caused febrile responses in rabbits.
These biological activities were typical of those of purified endotoxin
preparations.

However, on a weight to weight conçarison, GCE had not

more than 15% of the biological activity of purified gonococcal endo
toxin.

The specific gonococcal fraction of GCE was consistent with the

properties of a low molecular weight glycoprotein.

These low molecular

weight molecules could have aggregated spontaneously to form large com
plexes with molecular weights of 800,000 daltons or more.
The original objectives of this study were to characterize a gono
coccal specific antigen which was contained in a crude gonococcal extract.
The crude extract, containing a mixture of antigens currently is employed
in a radioimmunoassay for the quantification of anti-gonococcal activity
of human serum (36).

It was hypothesized, based on the extraction pro

cedure and previous work (Rudbach, unpublished data), that the specific
fraction of GCE was a protoplasmic polypeptide, glycoprotein, or nucleoprotein.

The possibility existed, however, that other cell components.
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such as endotoxin or pili, were important in the specific anti-gonococcal
reaction (SAGR).
Two general approaches were used in characterizing the antigen.
In the first approach chemical analyses were performed for protein, DNA,
and RNA; endotoxic activity was determined, and molecular size was esti
mated.

In the second approach GCE was treated by a variety of methods

designed to destroy or alter specific materials.
analyzed for capacity to inhibit SAGR.

GCE so treated was then

By this means it was hoped to

characterize the specific gonococcal fraction of GCE with respect to
activity in SAGR.

Any treatment which denatured or destroyed the gono

coccal specific fraction of GCE would result in an increase in the amount
of antigen required to inhibit by 50% the binding of GCE* with the spe
cific antibody.

Conversely, any treatment that increased solubility or

exposed more antigenic determinants would result in a decrease in the
amount of antigen required for 50% inhibition, reflecting an increase in
the capactiy of the treated GCE to inhibit SAGR.

Chemical and biological properties of GCE and their relationship to
specific gonococcal antigenic activity

A first step in the process of characterizing the gonococcal speci
fic antigen was to learn something of the overall chemical composition
of GCE.

This could indicate the direction subsequent investigation

should take.

By direct chemical analysis it was found that GCE was most

ly protein, but that there were amounts of RNA of up to 34% in some pre
parations.
GCE.

DNA was found to account for less than 1% of the weight of

These were the only chemical analyses performed because of the
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small amounts of GCE available.

The results of chemical analyses sug

gested that the gonococcal specific fraction of GCE could be a protein
or a nucleoprotein.

Although direct analyses for carbohydrate and ester-

bound lipid content were not performed, the contribution of these mater
ials to the gonococcal specific antigen was investigated in later exper
iments.
A variety of evidence suggested that the protein component of GCE
was important for the gonococcal specific antigenicity of GCE.

It was

found that the capacity of GCE to inhibit SAGR was greatly reduced when
GCE was digested with either pronase or trypsin.

Becasue the capacity

of GCE to inhibit SAGR was destroyed when the protein component of GCE
was destroyed, it was concluded that a protein moiety was part of the
gonococcal specific antigen.

In order to add confidence to this inter

pretation, radio-labeled GCE (GCE*) was treated directly With proteolytic
enzymes.

When the protein component of labeled GCE was destroyed by

digestion with proteolytic enzymes there was a great loss in antigenic
activity as indicated by a marked reduction in its binding with anti
bodies in the standard anti-gonococcal human serum.

From these results

it was confirmed that a protein moiety was essential to the antigenicicy
of GCE.
Because several GCE preparations contained appreciable amounts of
RNA, it was of interest to investigate the possible role of nucleic
acids in the gonococcal specific antigenic activity of GCE.

It was found

that GCE retained nearly full capacity to inhibit SAGR following incuba
tion of GCE with RNase or DNase.

These results suggested that nucleic

acids were not essential for the gonococcal specific antigenic activity
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of GCE.

In order to add confidence to the interpretation of these re

sults, as was done previously with proteolytic enzymes, radio-labeled
GCE was itself incubated with nucleases.

GCE* so treated retained most

of its origianl specific gonococcal antigenic activity as shown by no
decrease, or only a slight decrease, in binding activity.

It was con

cluded on the basis of these results that a nucleic acid component was
not essential to the gonococcal specific antigenic activity of GCE.
In addition to the experiments in which enzymatic treatments were
used to analyze the contributions of protein and nucleic acid components
to the gonococcal specific antigenic activity of GCE, other treatments
of GCE were performed to investigate contributions made by putative
carbohydrate or lipid components of GCE.

The possibility that carbohy

drate was part of the specific immunodeterminant group of GCE was inves
tigated by subjecting GCE to oxidation by periodate.

It was found that

GCE so treated lost much of its capacity to inhibit SAGR.

Although other

reactions might have taken place, these data were interpreted as indi
cating that destruction of carbohydrate component reduced the gonococcal
specific antigenic activity of GCE.
The possible role of an ester-bound lipid component was investigated
by subjecting GCE to saponification with KOH in methanol.

It was found

that following saponification, the capacity of GCE to inhibit SAGR in
creased slightly.

These results showed that no ester-bound lipid was

essential to the gonococcal specific antigenic activity of GCE.
The experiments discussed to this point were designed to investigate
contributions to the gonococcal specific antigenic activity of GCE made
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by specific classes of biological molecules.

It was hypothesized that

neither a lipid nor a nucleic acid component was essential.

Of the

classes of bio-molecules studied only a protein and a carbohydrate com
ponent were found to be important to the gonococcal specific antigenic
activity of GCE.

These results suggested that the gonococcal specific

antigenic fraction of GCE was a glycoprotein.
The following experiments represented a change in direction of the
approach to characterization of the gonococcal specific fraction of GCE.
In these experiments the relationship between GCE and two known gono
coccal components was studied.

Gonococcal endotoxin (LPS) and pili have

received considerable attention from other researchers (8, 17, 38-46, 52,
61) investigating the antigenicity of the gonococcus, and it was necessary
to determine the relationship of GCE to these components.
Endotoxin, which is a cell wall conçionent of gram negative bacteria,
has been shown to be defined best by its biological activities (48).

Two

biological properties of endotoxin are its toxicity for chick embryos
(15, 16, 59) and its abiltiy to produce a febrile response in rabbits
(47, 67).

GCE was compared to a preparation of purified gonococcal LPS

by these two assays.

It was found that on a weight to weight comparison,

GCE had not more than 15% of the biological activity of the purified endo
toxin.

These results were interpreted to indicate that endotoxin represented

15% by weight of the total composition of GCE.

If this endotoxic com

ponent were in fact the gonococcal specific fraction of GCE then purified
gonococcal endotoxin would be expected to have nearly a 10 fold greater
capacity than GCE to inhibit SAGR.

However, when GCE and gonococcal

endotoxin were compared in their capacities to inhibit SAGR, it was found
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that endotoxin had only one tenth of the capacity of GCE to inhibit SAGR.
It was, therefore, concluded that the specific fraction of GCE was not
represented by an antigenic determinant of gonococcal endotoxin.
It has been shown that colonial morphology of cultures of N. gonor
rhoeae could be correlated with virulence (28).

One physical character

istic that differentiates cells from virulent colony types from cells
from avirulent colony types is that virulent cells possess pili (25, 60).
In addition, a number of cytoplasmic factors have been described in cells
from other colony types (11, 51).

It was of interest to investigate the

relationship between these "virulence factors" and the gonococcal specific
fraction of GCE.
In order to determine if the gonococcal specific antigen was found
only in virulent cells, an extract of cells from a colony type represen
tative of avirulent gonococci was compared with GCE (which was prepared
from virulent cells).

The avirulent cells were shown by electron-

microscopy to lack pili.
T3GCE.

The extract of these cells was designated

It was found that T3GCE had less of a capacity to inhibit SAGR

than did GCE.

This suggested that the gonococcal specific antigen might

be virulence associated.
The fact that the gonococcal specific antigen was associated with
virulent cells raised the possibility that the antigen was in fact pili
or the subunit, pilin.

The only evidence obtained relevant to this point

was ultra violet absorption data for GCE.
absorption peak only at 260 nm.

GCE was found to have a UV

It is not known if gonococcal pili have

UV absorption spectra identical to & coli type I pili from Escherielia
coli; however, Brinton (6, 7) has shown that the latter have UV absorption
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peaks at 280 and 285 nm.
GCE and

The difference in absorption spectra between

coli pili was considered evidence that pili or pilin were not

a major component of GCE.

Physical properties of GCE and their relationship to specific
gonococcal antigenic activity

From the experiments discussed previously it was shown that the
gonococcal specific fraction of GCE was probably a glycoprotein assoc
iated with cells of virulent colony types.

The experiments discussed in

this section were designed to investigate the molecular size and shape,
the state of aggregation or disaggregation, and other physical properties
of the gonococcal specific antigenic fraction of GCE.
The heat stability of GCE was one of the first properties investi
gated.

It was found that the capacity of GCE to inhibit SAGR was not

reduced by heat treatments of 56"C for 30 min or boiling for 2 min.

In

several instances, in fact, the capacity of GCE to inhibit SAGR was in
creased by these treatments.

However, if GCE was boiled for longer than

2 min, the capacity to inhibit SAGR was reduced greatly.

Denaturation

of protein antigens is thought to destroy antigenic specificity by caus
ing unfolding of the peptide chain (cf. 1).

The moderate heat stability

of GCE was, therefore, considered evidence that the gonococcal specific
antigen, already thought to be a glycoprotein, was a small, linear or
loosely folded molecule, the antigenic specificity of which would not be
altered by further unfolding.

If aggregates of the specific antigen

formed, moderate heating could have disrupted such aggregates, thereby
exposing more antigenic determinants.

This could explain the increased
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capacity of GCE to inhibit SAGR after GCE was subjected to moderate heat
ing.

The fact that prolonged boiling of GCE reduced its capacity to in

hibit SAGR was consistent with the notion that the gonococcal specific
antigen had an essential protein moiety.

Prolonged boiling would be

expected to cause coagulation and loss of solubility of the antigen
(cf. 1) thereby decreasing the capacity of GCE to inhibit SAGR.
GCE was also tested for stability to treatment with acid and alkali.
When GCE was treated with 0.1 N NaOH for 1 h there was no loss of capa
city to inhibit SAGR.

Treatment with 0.1 N HCl resulted in a slight in

crease in the capacity of GCE to inhibit SAGR.

Acid conditions have

been shown to increase the solubility of many proteins (cf. 31).

Acid

treatment could have, again, disrupted aggregates of a small glycoprotein
by increasing the solubility of the subunits.

More antigenic determin

ants could have become available for antibody binding thereby increasing
the capacity of a given amount of GCE to inhibit SAGR.

The results of

these experiments are consistent with the hypothesis that the gonococcal
specific antigen was a small glycoprotein.
More direct evidence of the size and shape of the gonococcal spec
ific antigen was obtained when GCE was subjected to fractionation by gel
filtration and density gradient ultracentrifugation.

GCE was separated

into 3 major fractions by molecular sieving on Sephadex G-200.

The gono

coccal specific portion of GCE was eluted in the void volume.

Sephadex

G-200 gel excludes molecules of molecular weight greater than 800,000
daltons.

It was concluded, therefore, that the specific fraction of GCE

exists in a form with a molecular weight equal to or greater than
800,000.

It was noted that approximately 30% of the total radioactivity
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added to the column was not eluted which suggested that some fraction of
GCE binds Sephadex or was otherwise trapped in the gel matrix.
When GCE was fractionated by ultracentrifugation on a gradient of
10% to 50% sucrose, two peaks of high activity were found, one at each
extreme of the gradient.

This suggested either that the specific frac

tion of GCE existed in an aggregated, high molecular weight form and as
low molecular weight subunits, or that there were two distinct, specific
fractions, one of high molecular weight and one of low molecular weight.
It was thought that the portion of GCE not eluted from the Sephadex
column might correspond to the low molecular weight fraction from the
sucrose gradient.

In velocity gradient ultracentrifugation molecules

sediment at a rate proportional to their size (31).

However, a molecule,

even of macromolecular dimensions, that had a density less than that of
10% sucrose would not penetrate the gradient.

Lipids are the most

likely class of bio-molecules to have such low density.

It was possible,

therefore, that the non-sedimenting fraction of high gonococcal specific
activity represented a lipid moiety.

However, the fact that the activity

of GCE was not reduced by saponification showed that an esterified lipid
was not essential for the specific antigenicity of GCE.

Therefore, the

non-sedimenting fraction of high gonococcal specific antigenic activity
most probably represented a low molecular weight moiety.

A model for the structure or GCE

This study has shown that GCE is a heterogeneous mixture of cellu
lar components containing at least one moiety that is antigenically
specific for the gonococcus.

Fractionation by molecular sieving and
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velocity gradient untracentrifugation showed that while GCE contained a
wide range of molecular sized, the specific activity was found in only
a small portion of the total.

Many of the problems encountered in es

tablishing the inhibition assay and in interpreting results may have been
attributable to effects of these antigenically non-specific materials.
Because much of the specific antigenic activity of GCE was destroyed
by digestion with proteolytic enzymes and by oxidation with periodate,
it was felt that the gonococcal specific antigen was a glycoprotein.

It

was thought that the specific antigen was a large molecule because the
high activity fraction of GCE was eluted in the exclusion volume from
Sephadex G-200.

Other evidence, such as heat stability and position on

sucrose velocity gradient untracentrifugation, however, suggested that
the gonococcal specific antigen could exist as a small molecule and that
the high molecular weight fraction represented an aggregation of these
small glycopeptides.
Moderate heat treatment, treatment with mild acid, and saponifica
tion are treatments that would be expected to disrupt aggregates of
glycopeptides.

One effect of disrupting an aggregate of antigenic mole

cules would be to expose more antigenic determinants which would result
in an increase in reactivity of the antigen with antibodies.

That these

treatments did, in fact, increase this activity of GCE indicated that
the gonococcal specific antigen formed large aggregates spontaneously.
This view was supported by the demonstration of a fraction with high gono
coccal specific antigenic activity in the upper layers of the sucrose
velocity gradient untracentrifuge tube.
A schematic representation of the hypothetical structure of the
gonococcal specific antigen is shown in Figure 20.

Figure 20. Schematic model of the structure of the gonococcal specific
antigen. The polypeptide component of the antigen is indicated by solid
black lines; the carbohydrate component is indicated by solid black
circles. Integral to this model is the ability of the monomers to spon
taneously aggregate into micellar bundles.

Monomers

Aggregate
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Relationship of GCE to other known gonococcal antigens

Because there already was much known about antigens of the gonococus it was of interest to compare the properties of GCE with the
properties of antigens reported by others.

Antigens reported by others

include cell wall extracts (17, 38-46, 61), pili (8, 52), and proto
plasmic antigens (2, 3, 11, 13, 29, 30, 51, 54, 58).

GCE was found to

share some characteristics with some of these antigens.

However, because

characterization of these antigens and GCE has been incomplete, the
exact relationship between GCE and other reported antigens could not be
determined precisely.
Maeland (39-41) has extracted gonococcal endotoxin with phenol-water
and aqueous ether.
3.

He found two antigenic determinants designated a and

Determinant a was found to be a polysaccharide reactive in complement

fixation tests (39).
for N. gonorrhoeae.

This antigen showed some degree of specificity
The 3 determinant was proteinaceous in nature and

also reacted in complement fixation tests but was found to cross react
extensively with other Neisseria species (39).

The 3 determinant has

been characterized further as an acidic glycoprotein (3).

Because endo

toxin was found to have no importance in the specificy of GCE, there is
probably little relationship between these antigens and GCE.
Buchanan et al. (8) have worked with gonococcal pili in a radioim
munoassay for the detection of antibodies against pili antigens in sera
of human patients.

They have demonstrated considerable serological

specificity with this assay.

Recently, Novotny and Turner (50) have

shown that the antigens of gonococcal pili are highly strain (sic) spec
ific.

They investigated 31 strains of N. gonorrhoeae by gel diffusion
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against antisera raised against pili of 3 strains.
tions of identity between strains.

They found few reac

These results cast some doubt on the

usefulness of gonococcal pili as diagnostic antigens.
Although the presence of pili on the cell surface has been shown to
be the major morphological feature distinguishing virulent gonococci
from avirulent gonococci (25, 60), pili are not the only distinguishing
feature.

Cheng et al. (11) have isolated from protoplasm of cells from

colony type T1 a toxic, heat labile polypeptide, designated B, that was
not found in protoplasm of cells from colony type T3 of the homolgous
isolate.

Also, Pierce et al. (51) isolated a polypeptide unique to

virulent cells that was shown by gel diffusion to be distinct from LPS,
pili, and the B antigen described by Cheng.
nated Ag-1.

This polypeptide was desig

Both the B antigen and Ag-1 were eluted in the exclusion

volume from Sephadex G-200, and both were destroyed by proteolytic en
zymes (11, 51).

The active fraction of GCE appears to be similar to

Ag-1 and the B antigen in as much as all are eluted in the exclusion
volume from Sephadex G-200, all are destroyed by proteolytic anzymes,
and all are associated with cells from T1 colony types.

Also, GCE pos

sessed toxicity for chick embryos similar to that of the B antigen.
Toxicity of Ag-1 was not determined (51).

However, the active fraction

of GCE could not be identified completely with Ag-1 or the B antigen at
this time.
Another antigen that may bear some relation to GCE was character
ized by Danielsson et al. (13).

They passed gonococcal protoplasm through

Sephadex G-200 and found a component in the first half of the first elution peak that reacted in complement fixation tests with sera of 20% of
males and 73% of females who were culturally positive for N. gonorrhoeae.
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No positive reactions were found in negative controls (54).

Because this

antigen was not characterized biochemically its relationship to the speci
fic fraction of GCE cannot be determined.
Gonococcal ribosomes have been used with promising results as skin
test antigens in guinea pigs (26).

However, studies employing hyperim-

munized animals have been of questionable value when applied to the human
system because of the minimal immunological response elicited by the
natural infection in humans.

However, in other systems (cf. 26) ribo

somes have proved to provide highly specific antigens.
parations of GCE did have a high RNA content.

Also, some pre

Therefore, the possibility

that gonococcal ribosomes had a role in the antigenicity of GCE was con
sidered.

It was found that treatment with RNase had no effect on the

specific activity of GCE which suggested that intact ribosomes were not
essential for the antigenicity of GCE.

However, the possibility that the

specific gonococcal fraction of GCE was a ribosomal protein could not be
excluded.
Much more work remains to be done before the specific antigens of
the gonococcus will be fully characterized.

This study has contributed

to that process and information was obtained which will help to refine
an assay for
sera.

the detection of gonococcal specific antibodies in human

CHAPTER V

SUMMARY

An antigen specific for Neisseria gonorrhoeae contained in an ethanol
precipitate of a surfactant extract of T1 phase gonococci was character
ized by a variety of techniques.

A limited chemical analysis indicated

that the crude extract (GCE) was mostly protein but that some preparations
contained up to 37% RNA.

The extract was biologically active, in that it

had 1/20 and 1/7 the potency of purified gonococcal LPS in assays of chick
embryo lethality and pyrogenicity in rabbits, respectively.
The major portion of the project was devoted to investigating the
chemical, physical, and biological properties of GCE and their relation
to specific gonococcal antigenic activity.

The model system employed

human sera from patients naturally infected with N. gonorrhoeae.

Gono

coccal specific antibodies in the human serum were detactable with a radio
immunoassay employing

labeled GCE (GCE*).

This specific antigono

coccal reaction (SAGR) could be inhibited by the addition of cold GCE.
Many properties of the gonococcal specific antigen were investigated by
subjecting cold GCE to various treatments and then assaying this treated
GCE for capacity to inhibit SAGR.

It was found that gonococcal specific

antigenic activity was increased by the following treatments:

1) heating

at 56'C, 1 h; 2) treatment with 0.1 N HCl, 30 min, 25°C; 3) saponification
by 0.1 N KOH in methanol.

Gonococcal specific antigenic activity was de

creased by the following treatments:
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1) heating 5 min in a boiling water
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bath; 2) oxidation by periodate; 3) enzymatic digestion with trypsin or
pronase.

It was found that gonococcal specific antigenic activity was

unaffected by the following treatmens:

1) heating 2 min in a boiling

water bath; 2) treatment with 0.1 N NaOH, 30 min, 25°C; 3) enzymatic diges
tion with DNase or RNase.

It was found that a GCE preparation from non-

pi liated gonococci of T3 phase colony types lacked the gonococcal specific
antigenic activity exhibited by GCE preparations from piliated bacteria
of T1 phase colonies.

It was also found that gonococcal LPS lacked the

gonococcal specific antigenic activity exhibited by GCE.
The molecular size of the gonococcal specific antigen was investi
gated by fractionating labeled GCE by molecular sieving on Sephadex G-200
and by velocity gradient ultracentrifugation.

Results of both fractiona

tion methods revealed that gonococcal specific antigenic activity was
contained in a high molecular weight fraction.

In addition, a low mole

cular weight fraction exhibiting gonococcal specific antigenic activity
was recovered from the top of the sucrose gradient.
A model for the structure of the gonococcal specific antigen was
proposed to account for the above findings.

It was hypothesized that the

gonococcal specific antigen was a low molecular weight, linear or loosely
folded, glycoprotein.
occur spontaneously.

Large, apparently stable, aggregates appeared to
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